Zdrowie i gospodarka · 21/12/2021

FDA Extends Comment Period for Real-World Data Drug Submissions Guidance

The US Food and Drug Administration (FDA) is extending the comment period for its draft guidance on data standards for drug and biological product submissions containing real-world data, in response to requests from interested persons, following its notice of availability published in the Federal Register on October 22, 2021.